Each week, Crowell & Moring’s State Attorneys General team highlights significant actions that State AGs have taken. See our State Attorneys General page for more insights. Below are the updates from April 30-May 7, 2026:

Multistate

  • A bipartisan coalition of 45 state attorneys general submitted a letter to the U.S. Department of Labor urging the agency to impose new transparency requirements on pharmacy benefit managers (PBMs) — third-party intermediaries that administer prescription drug benefits on behalf of insurers and exercise control over which drugs are covered and how much they cost for nearly all Americans with health insurance. The coalition called on the Labor Department to mandate that PBMs disclose how they generate revenue on a biannual basis and to allow employers that fund health insurance plans to conduct independent audits of PBM operations. The attorneys general also urged the Department to clarify that any new federal transparency rule would not preempt existing state PBM regulations under the Employee Retirement Income Security Act of 1974 (ERISA) — a federal statute that PBMs have previously invoked in efforts to avoid state oversight.
Continue Reading State AG News: Pharmaceuticals, Infrastructure, Fraud Schemes (April 30-May 7, 2026)

In mid-April 2026, a bipartisan coalition of 45 State Attorneys General (AG) submitted a formal letter to the U.S. Department of Labor (DOL) expressing their collective support for a proposed rule (Improving Transparency into Pharmacy Benefit Manager Fee Disclosure, or RIN 1210-AB37). If enacted as drafted, the rule will require pharmacy benefit managers (PBM) to

On February 20, 2026, the Department of Justice’s Antitrust Division (DOJ) and Ohio Attorney General (Ohio AG) sued OhioHealth Corporation (OhioHealth), alleging that OhioHealth had unlawfully restrained trade in the market for general acute care inpatient hospital services in violation of the Sherman Act and Ohio’s antitrust statute. The action is further evidence that antitrust

Each week, Crowell & Moring’s State Attorneys General team highlights significant actions that State AGs have taken. See our State Attorneys General page for more insights. Below are the updates from January 8-14, 2026:

Alabama

  • Attorney General Marshall settled a lawsuit with Cullman Clinic and its administrator for allegedly administering dangerous, unapproved weight-loss drugs to patients in violation of the Alabama Deceptive Trade Practices Act (§ 8-19-1 et seq.). Under the settlement, the clinic must halt the use of unapproved drugs, pay $75,000 in restitution and penalties, and implement enhanced patient safety protocols.
Continue Reading State AG News: Environmental Regulation, Consumer Protection, Patient Safety (January 8-14, 2026)